Home / Peptide legality / West Virginia
Are peptides legal in West Virginia?
Peptides sit in a legal gray zone in West Virginia, where FDA-approved products are legal by prescription while most research peptides and compounded copies have no lawful dispensing pathway.
Legal status overview
Peptides sit in a legal gray zone in West Virginia. The state has no peptide-specific statute, so legality is set by federal FDA drug law and the West Virginia Board of Pharmacy compounding rules. FDA-approved products such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) are legal only with a valid prescription, while research peptides like BPC-157 and TB-500 have no approved prescribing route. The Board has specifically cautioned pharmacies about compounding semaglutide. This is information, not medical or legal advice.
Key points
- West Virginia has no statute that names peptides or research chemicals as a distinct legal category, so status is governed by federal FDA law and Board of Pharmacy compounding rules. [2]
- The West Virginia Board of Pharmacy issued a statement addressing semaglutide compounding and warned that compounding in a way that fails to conform with governing law may lead to enforcement action. [1]
- Compounding pharmacies may only use bulk drug substances that comply with FDA requirements under Sections 503A and 503B of the FD&C Act. [1]
- Brand-name GLP-1 products such as Ozempic® (semaglutide) and Mounjaro® (tirzepatide) are legal only when prescribed by a licensed provider. [2]
- After the FDA declared the GLP-1 shortages resolved, the shortage pathway that allowed routine compounding of copies closed, leaving only narrow documented-need exceptions. [3]
- Compounded semaglutide and tirzepatide are not FDA-approved; not a generic; not evaluated by the FDA, and cannot be essentially a copy of a commercially available product. [3]
- BPC-157 was removed from the FDA 503A Category 2 list in April 2026 and recommended by the Pharmacy Compounding Advisory Committee in July 2026, but it is not yet approved for compounding pending final rulemaking. [5]
- Human growth hormone and somatropin are prescription-only under federal law and cannot be lawfully distributed for anti-aging or performance use. [2]
Compound-by-compound status
| BPC-157 Gray area | No FDA approval and no USP monograph; removed from 503A Category 2 in April 2026 and recommended for the list in July 2026, but not yet permitted pending final rulemaking. No lawful human-use dispensing pathway in West Virginia today. |
|---|---|
| GLP-1 class, including Wegovy® (semaglutide) and Zepbound® (tirzepatide) Restricted | Brand-name products are legal by prescription. Compounded versions are not FDA-approved; not a generic; not evaluated by the FDA, and the West Virginia Board of Pharmacy has cautioned against compounding a commercially available drug. |
| TB-500 Gray area | Unapproved research peptide with no FDA approval and no lawful human-use prescribing pathway in West Virginia. |
| Growth hormone / somatropin Restricted | FDA-approved somatropin products are prescription-only for approved indications; federal law restricts distribution for unapproved uses. |
Frequently asked questions
Are peptides legal in West Virginia?
There is no peptide-specific law in West Virginia. FDA-approved peptide medications are legal with a valid prescription, while unapproved research peptides such as BPC-157 and TB-500 have no lawful human-use dispensing pathway. This is information, not advice.
Can a pharmacy compound semaglutide in West Virginia?
The West Virginia Board of Pharmacy has cautioned that compounding semaglutide must conform with governing law and use FDA-compliant bulk substances. Since the shortage ended, routine compounding of copies is no longer permitted, and compounded semaglutide is not FDA-approved; not a generic; not evaluated by the FDA.
Is BPC-157 legal in West Virginia?
BPC-157 sits in a federal gray zone. It was removed from the FDA 503A Category 2 list in April 2026 and recommended for the compounding list in July 2026, but it is not yet permitted pending final rulemaking, and it has no FDA approval.
Can I buy peptides labeled research use only?
Products labeled research use only are not authorized for human use, and selling them for human consumption has no lawful pathway in West Virginia regardless of the label.
Who regulates peptides in West Virginia?
The West Virginia Board of Pharmacy oversees state compounding and dispensing, working alongside the FDA and the federal 503A and 503B framework.
Sources
- WVBOP Statement on Semaglutide Compounding - West Virginia Board of Pharmacy (retrieved 2026-09-21)
- West Virginia Peptide Laws & Regulations - PeptideLaws.com (retrieved 2026-09-21)
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize - FDA (retrieved 2026-09-21)
- Above the Federal Floor: How States Are Regulating Compounded GLP-1s and Peptides - National Law Review (retrieved 2026-09-21)
- BPC-157 in 2026: Why Regulatory Limbo Is Not the Same as a Green Light - Holt Law (retrieved 2026-09-21)
Last researched: 2026-09-21.